Loading clinical trials...

Short Term Results of Tele-Rehabilitation | Clinical Trials | Clareo Health

COMPLETEDNA

Short Term Results of Tele-Rehabilitation

Short Term Outcomes of Tele-Rehabilitation in Patients With Post-Covid Syndrome

NCT05381675•Harran University

Summary

Most people who have coronavirus disease (COVID-19) recover completely without any sequelae. However, some patients continue to experience symptoms of COVID-19 even though their tests turn negative. This clinical spectrum that occurs after acute infection is called the post-COVID syndrome (PCS). Dyspnea, pain, decreased exercise capacity, limitations in activities of daily living, poor sleep quality, anxiety and depression are common symptoms in PCS. The aim of our study is to examine the effect of tele-rehabilitation-based exercise program on dyspnea, pain, functional capacity, sleep quality, anxiety and depression in individuals with PCS.

Eligibility

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Being between the ages of 18-75,
•Being in stable medical condition, conscious and cooperative,
•Having had COVID and continuing symptoms
•Volunteering to participate in the study,
•Own a device that can be connected online independently or with support from family members.

Exclusion Criteria

•SpO2 \< 92%,
•Hypotension (Systolic Blood Pressure \< 90 mmHg or Diastolic Blood Pressure \< 60mmHg)
•Having chronic respiratory disease (COPD, Asthma, etc.)
•Having a stroke or neurodegenerative disease.
•Not being willing to participate in the study

Locations (1)

İstanbul University-Cerrahpasa

Istanbul, Turkey (Türkiye)

Key Dates

Start Date

May 20, 2022

Primary Completion Date

May 20, 2023

Completion Date

August 1, 2023

Last Updated

August 29, 2023

Enrollment

ACTUAL participants

Conditions

COVID-19Dyspnea

Interventions

Tele-rehabillitation

OTHER

Prescribed Exercise Program

OTHER

A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes

NCT07221162

COVID-19

View study

RECRUITINGNA

Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments

NCT06082518

Post COVID-19 ConditionPost-COVID-19 Syndrome+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 29, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Short Term Results of Tele-Rehabilitation

Inclusion Criteria

Exclusion Criteria

A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes

Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

Dime La VerDAD: Verify, Debunk, and Disseminate

Positron Emission Tomography (PET) Imaging of Thrombosis